rosiglitazone has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, MA; Chensue, SW; Menees, SB; Moseley, RH | 1 |
1 other study(ies) available for rosiglitazone and Chemical and Drug Induced Liver Injury, Chronic
| Article | Year |
|---|---|
Hepatic injury in a patient taking rosiglitazone.
Topics: Biopsy; Chemical and Drug Induced Liver Injury, Chronic; Diabetes Mellitus, Type 2; Diagnosis, Differential; Fatal Outcome; Humans; Hypoglycemic Agents; Male; Middle Aged; Rosiglitazone; Thiazolidinediones | 2005 |